Associate Professor, Pediatrics, Baylor College of Medicine
Pediatric Hematology & Oncology
Dr. Stephen Gottschalk, MD
|
|
Give Review
Stephen Gottschalk practices Pediatric Hematology & Oncology. He studied medicine at Baylor College of Medicine. Stephen Gottschalk is a published doctor as well. He has 27 publications published. The latest was: Characterization and Functional Analysis of scFv-Based Cars to Redirect T Cells to IL13Rα2-Positive Glioma.
Publications
- Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients.
- Characterization and Functional Analysis of scFv-Based Cars to Redirect T Cells to IL13Rα2-Positive Glioma.
- Toward immunotherapy with redirected T cells in a large animal model: ex vivo activation, expansion, and genetic modification of canine T cells.
- T-cell immunotherapy: looking forward.
- Engager T cells: A new class of antigen-specific T cells that redirect bystander T cells.
- Cell carriers to attack glioma.
- Complementation of Antigen-presenting Cells to Generate T Lymphocytes With Broad Target Specificity.
- T cells redirected to interleukin-13Rα2 with interleukin-13 mutein-chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Rα1.
- Design and development of therapies using chimeric antigen receptor-expressing T cells.
- Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem ce...
- T-cell engager-armed oncolytic vaccinia virus significantly enhances antitumor therapy.
- Is cancer gene therapy an empty suit?
- Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
- Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma.
- Targeting EBV's Achilles' heel with antigen-specific T cells.
- T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma.
- Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation.
- Cancer-associated fibroblasts as targets for immunotherapy.
- Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections.
- Interleukin-13 receptor α2: glioma's unlucky receptor?
- Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients.
- Genetically modified T-cell therapy for osteosarcoma.
- A vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreading.
- Adoptive cell therapy for sarcoma.
- Genetically Modified T Cells to Target Glioblastoma.
- TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy.
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Education
-
Baylor College of Medicine -
University of Gottingen Faculty of Medicine
Hospital
-
Texas Children's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Laurence Cooper, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Donald L. Yee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nabil M. Ahmed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Najat D. Bitar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Holly B. Lindsay, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lanelle V. Nakamura, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Demetrios Petropoulos, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|